Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The succinic acid maker BioAmber has agreed to pay Reverdia royalties for the right to use certain intellectual property for making the biobased chemical. Reverdia is a joint venture between DSM and Roquette. The parties aren’t disclosing the technology in question or the amount of money that will change hands. The agreement is a “constructive solution” that avoids confrontation and enables both firms to continue to use their own yeast-based routes to succinic acid, says BioAmber CEO Jean-François Huc.
This article has been sent to the following recipient: